Private Equity Reshapes Indian Healthcare: From Hospitals to Holistic Wellness
As clinical wellness gains ground, investors and entrepreneurs push India’s healthcare evolution beyond treatment into prevention, lifestyle, and evidence-based care.
The New Wave of Healthcare Investment
Private equity (PE) in India’s healthcare is undergoing a significant shift. While traditional investments focused on hospitals, diagnostics, and pharma, a 60% surge in deals over the past two years reveals a broader vision: scalable, purpose-driven wellness models.
- Investors now prioritize preventive care, lifestyle management, and holistic wellbeing.
- This evolution reflects global trends and rising consumer demand for long-term, sustainable health solutions.
From Illness to Wellness: The Emerging Paradigm
The Indian healthcare narrative is moving from curing diseases to caring for the whole person. This includes:
- Specialty clinics, secondary care, and evidence-based therapies.
- A hybrid of Ayurveda, yoga, and modern diagnostics creating measurable health outcomes.
This shift is transforming healthcare into a continuum, rather than an episodic service.
Faizal Kottikolon’s Vision for Clinical Wellness
At the forefront is entrepreneur Faizal Kottikolon, founder of KEF Holdings and Meitra Hospital. His latest venture, Tulah, represents a new breed of clinical wellness centres—merging traditional healing with modern science.
- Kottikolon envisions Tulah as a national model, backed by external capital to scale efficiently.
- “India needs hundreds of hospitals,” he says, “but it also needs to move towards wellness that is deep, evidence-led, and clinically validated.”
Tulah targets a niche but growing market segment where wellness is not luxury—it’s science-based, outcome-driven healthcare.
The $7 Trillion Opportunity
Globally, wellness is a $7 trillion market, but much of it remains superficial—focused on retreats and luxury spas. Tulah and similar ventures aim to:
- Create validated wellness outcomes, measurable through diagnostics.
- Reposition ancient Indian therapies within a framework that appeals to global and urban Indian consumers.
This clinical wellness approach may be more capital-intensive, but it has the potential to redefine how we approach preventive health.
Can Clinical Wellness Go Mass-Market?
The current model targets the affluent, raising concerns about accessibility and scalability:
- Will clinical wellness remain a premium investor zone?
- Or can innovation, technology, and PE capital bring costs down and open doors for mass adoption?
Kottikolon’s belief in external capital is central: “I didn’t want to invest hundreds of millions myself… That’s where I appreciate foreign and domestic investment.”
The answer lies in how quickly wellness can align with affordability, scalability, and measurable impact.
